Lubner David Charles
Transactions
50
Companies
11
Filings
10
CIK
0001572000
Recent Transactions
- Purchase
- Award
- Award
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition from Tender
- Disposition to Issuer
- Gift
- Exercise/Conversion
- Sale
- Exercise/Conversion
- Disposition to Issuer
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition from Tender
- Award
- Award
- Award
- Award
- Award
- Purchase
- Award
- Award
- Award
- Award
- Conversion
- Conversion
- Award
- Award
- Award
- Award
- Award
- Award
- Award
Companies
11Arcellx, Inc.
Director
- $BRVE
Braveheart Bio, Inc.
Director
CARGO Therapeutics, Inc.
Director
- $CBIO
CRESCENT BIOPHARMA, INC.
Director
- $IRON
Disc Medicine, Inc.
Director
- $DYN
Dyne Therapeutics, Inc.
Director
Nightstar Therapeutics plc
Director
POINT Biopharma Global Inc.
Director
Ra Pharmaceuticals, Inc.
Executive VP and CFO
TETRAPHASE PHARMACEUTICALS INC
SVP and CFO
- $VOR
Vor Biopharma Inc.
Director
Recent Filings
10- 4
Lubner David Charles
Aug 7, 2026
- 4
Lubner David Charles
Jun 9, 2026
- 4
Lubner David Charles
Jun 3, 2026
- 4
Lubner David Charles
Apr 28, 2026
- 4
Lubner David Charles
Apr 28, 2026
- 4
Lubner David Charles
Jan 20, 2026
- 4
Lubner David Charles
Aug 19, 2025
- 4
Lubner David Charles
Jun 23, 2025
- 4
Lubner David Charles
Jun 20, 2025
- 4
Lubner David Charles
Jun 3, 2025
Address
C/O BRAVEHEART BIO, INC. ONE LETTERMAN DR., BLDG. A, SUITE A4-300
SAN FRANCISCO, CA, 94129